Research roundup: Recent grants and publications for Emory faculty and staff
Emory News Center
12 April 2022https://news.emory.edu/stories/2022/04/er_research_roundup_april_14-04-2022/story.html

Among others, a grant is: Low dose naltrexone to be studied for chronic neuropathic pain

Response to: Invasive Treatments for Low Back Disorders and the ACOEM Practice Guidelines

J Occup Environ Med
01 February 2022
https://journals.lww.com/joem/Fulltext/2022/02000/Response_to__Invasive_Treatments_for_Low_Back.20.aspx

Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study

Pain Manag
15 March 2022
https://pubmed.ncbi.nlm.nih.gov/35289682/

Aim: To evaluate the use of low-dose naltrexone (LDN) as a broad-spectrum analgesic.

The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain

Expert Opin Pharmacother
04 April 2022
https://pubmed.ncbi.nlm.nih.gov/35354341/

Pharmacist Michelle Moser, LDN Key to Success (LDN, low dose naltrexone)

Nonopioid Analgesic, Nonpharmacologic Options for Pain Management Reviewed

Drug Topics
24 March 2022
https://www.drugtopics.com/view/nonopioid-analgesic-nonpharmacologic-options-for-pain-management-reviewed